98 related articles for article (PubMed ID: 10873638)
1. Involvement of the Ras/MAPK signaling pathway in the modulation of urokinase production and cellular invasiveness by transforming growth factor-beta(1) in transformed keratinocytes.
Santibáñez JF; Iglesias M; Frontelo P; Martínez J; Quintanilla M
Biochem Biophys Res Commun; 2000 Jul; 273(2):521-7. PubMed ID: 10873638
[TBL] [Abstract][Full Text] [Related]
2. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas.
Iglesias M; Frontelo P; Gamallo C; Quintanilla M
Oncogene; 2000 Aug; 19(36):4134-45. PubMed ID: 10962574
[TBL] [Abstract][Full Text] [Related]
3. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
Santibáñez JF; Frontelo P; Iglesias M; Martínez J; Quintanilla M
J Cell Biochem; 1999 Jul; 74(1):61-73. PubMed ID: 10381262
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta-1 and amphiregulin act in synergy to increase the production of urokinase-type plasminogen activator in transformed breast epithelial cells.
Giusti C; Desruisseau S; Ma L; Calvo F; Martin PM; Berthois Y
Int J Cancer; 2003 Jul; 105(6):769-78. PubMed ID: 12767061
[TBL] [Abstract][Full Text] [Related]
5. JNK mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes.
Santibañez JF
FEBS Lett; 2006 Oct; 580(22):5385-91. PubMed ID: 16989819
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes.
Santibáñez JF; Guerrero J; Quintanilla M; Fabra A; Martínez J
Biochem Biophys Res Commun; 2002 Aug; 296(2):267-73. PubMed ID: 12163012
[TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP inhibits TGFbeta1-induced cell-scattering and invasiveness in murine-transformed keratinocytes.
Santibáñez JF; Olivares D; Guerrero J; Martínez J
Int J Cancer; 2003 Dec; 107(5):715-20. PubMed ID: 14566820
[TBL] [Abstract][Full Text] [Related]
8. SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes.
Kocic J; Bugarski D; Santibanez JF
Eur J Cancer; 2012 Jul; 48(10):1550-7. PubMed ID: 21798735
[TBL] [Abstract][Full Text] [Related]
9. Urinary-type plasminogen activator (uPA) expression and uPA receptor localization are regulated by alpha 3beta 1 integrin in oral keratinocytes.
Ghosh S; Brown R; Jones JC; Ellerbroek SM; Stack MS
J Biol Chem; 2000 Aug; 275(31):23869-76. PubMed ID: 10791952
[TBL] [Abstract][Full Text] [Related]
10. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner.
Nguyen DH; Catling AD; Webb DJ; Sankovic M; Walker LA; Somlyo AV; Weber MJ; Gonias SL
J Cell Biol; 1999 Jul; 146(1):149-64. PubMed ID: 10402467
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
Schepers H; Wierenga AT; Eggen BJ; Vellenga E
Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
[TBL] [Abstract][Full Text] [Related]
14. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
[TBL] [Abstract][Full Text] [Related]
15. ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion.
Tobar N; Villar V; Santibanez JF
Mol Cell Biochem; 2010 Jul; 340(1-2):195-202. PubMed ID: 20204677
[TBL] [Abstract][Full Text] [Related]
16. Genistein and curcumin block TGF-beta 1-induced u-PA expression and migratory and invasive phenotype in mouse epidermal keratinocytes.
Santibáñez JF; Quintanilla M; Martínez J
Nutr Cancer; 2000; 37(1):49-54. PubMed ID: 10965519
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways.
Mahabeleshwar GH; Das R; Kundu GC
J Biol Chem; 2004 Mar; 279(11):9733-42. PubMed ID: 14699120
[TBL] [Abstract][Full Text] [Related]
18. Cooperativity between the Ras-ERK and Rho-Rho kinase pathways in urokinase-type plasminogen activator-stimulated cell migration.
Jo M; Thomas KS; Somlyo AV; Somlyo AP; Gonias SL
J Biol Chem; 2002 Apr; 277(14):12479-85. PubMed ID: 11805108
[TBL] [Abstract][Full Text] [Related]
19. A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation.
Kobayashi H; Suzuki M; Kanayama N; Terao T
Clin Exp Metastasis; 2004; 21(2):159-66. PubMed ID: 15168733
[TBL] [Abstract][Full Text] [Related]
20. Spred2 inhibits TGF-beta1-induced urokinase type plasminogen activator expression, cell motility and epithelial mesenchymal transition.
Villar V; Kocić J; Santibanez JF
Int J Cancer; 2010 Jul; 127(1):77-85. PubMed ID: 19908229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
